We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+13.62%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$87M
AUM Growth
-$6.82M
Cap. Flow
+$46M
Cap. Flow %
52.86%
Top 10 Hldgs %
19.17%
Holding
838
New
190
Increased
180
Reduced
205
Closed
92

Sector Composition

Rank Sector Weight
1 Technology 44.1%
2 Consumer Discretionary 19.26%
3 Financials 4.57%
4 Healthcare 4.2%
5 Communication Services 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
176
Chubb
CB
$134B
$49K 0.06%
317
HPQ icon
177
HP
HPQ
$26.6B
$49K 0.06%
1,554
+179
+13% +$4.94K
IYE icon
178
iShares US Energy ETF
IYE
$1.79B
$49K 0.06%
+1,877
New +$46.2K
PRU icon
179
Prudential Financial
PRU
$42.2B
$48K 0.06%
532
+88
+20% +$7.53K
USMV icon
180
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$48K 0.06%
702
-152
-18% -$10.3K
AMT icon
181
American Tower
AMT
$79B
$47K 0.05%
200
PLD icon
182
Prologis
PLD
$133B
$47K 0.05%
450
AFL icon
183
Aflac
AFL
$60.7B
$46K 0.05%
903
+162
+22% +$7.77K
EMN icon
184
Eastman Chemical
EMN
$8.55B
$46K 0.05%
419
+94
+29% +$10.2K
KMI icon
185
Kinder Morgan
KMI
$70.1B
$46K 0.05%
2,795
+516
+23% +$7.88K
TSN icon
186
Tyson Foods
TSN
$19.9B
$46K 0.05%
622
+358
+136% +$24.7K
CVX icon
187
Chevron
CVX
$386B
$45K 0.05%
431
+58
+16% +$5.66K
IHI icon
188
iShares US Medical Devices ETF
IHI
$3.47B
$45K 0.05%
822
-150
-15% -$8.32K
LYB icon
189
LyondellBasell Industries
LYB
$20.7B
$45K 0.05%
435
+65
+18% +$6.45K
XBI icon
190
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$45K 0.05%
333
MET icon
191
MetLife
MET
$61.5B
$44K 0.05%
725
-159
-18% -$8.77K
GILD icon
192
Gilead Sciences
GILD
$168B
$43K 0.05%
675
-133
-16% -$8.58K
KEY icon
193
KeyCorp
KEY
$24.3B
$43K 0.05%
2,173
-282
-11% -$5.44K
NI icon
194
NiSource
NI
$20.1B
$43K 0.05%
1,818
+393
+28% +$8.86K
ABBV icon
195
AbbVie
ABBV
$442B
$42K 0.05%
389
+76
+24% +$8.13K
CCI icon
196
Crown Castle
CCI
$31.3B
$42K 0.05%
245
+59
+32% +$9.45K
HBAN icon
197
Huntington Bancshares
HBAN
$35.9B
$42K 0.05%
2,716
+391
+17% +$5.86K
IP icon
198
International Paper
IP
$22.1B
$42K 0.05%
827
+54
+7% +$2.63K
PANW icon
199
Palo Alto Networks
PANW
$313B
$42K 0.05%
792
-4,212
-84% -$250K
PNC icon
200
PNC Financial Services
PNC
$101B
$42K 0.05%
243
+5
+2% +$825

Similar funds

Alpha DNA Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Alpha DNA Investment Management held 838 positions worth $87M, down 7.3% from $93.9M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alpha DNA Investment Management deployed $46M of net new capital in Q1 2021, opening 190 new positions and adding to 180 existing holdings. Its largest new stake was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $1.87M trimmed.

  • Alpha DNA Investment Management's largest Q1 2021 buy was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.
  • Alpha DNA Investment Management added most to iShares Russell 2000 ETF in Q1 2021, an estimated $49.7M increase.
  • Alpha DNA Investment Management's biggest Q1 2021 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $1.87M.
  • Alpha DNA Investment Management fully exited BlackLine in Q1 2021, selling an estimated $475K.
  • Alpha DNA Investment Management's ten largest holdings make up 19% of its $87M portfolio in Q1 2021.
  • Alpha DNA Investment Management opened 190 new positions and closed 92 in Q1 2021.
  • Alpha DNA Investment Management's portfolio value fell 7.3% quarter-over-quarter to $87M.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.